BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26393959)

  • 1. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
    Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
    Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
    Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
    Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new endoscopic staging system for hereditary hemorrhagic telangiectasia.
    Reh DD; Yin LX; Laaeq K; Merlo CA
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).
    Peterson AM; Kallogjeri D; Spitznagel E; Chakinala MM; Schneider JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):999-1005. PubMed ID: 33022056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
    Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
    Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
    Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
    Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
    Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
    Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
    Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
    Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan.
    Hayama M; Maeda Y; Shikina T; Tatehara S; Inokuchi G; Hoag JB; Sato T; Obata S; Nakatani A; Amano Y; Hida E; Nibu KI; Inohara H
    Auris Nasus Larynx; 2022 Jun; 49(3):415-420. PubMed ID: 34857410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study.
    Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G
    Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
    Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
    J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
    Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
    Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
    Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited.
    McDonald J; Kornish J; Stevenson DA; Hanson-Kahn A; Balch H; James J; Naik H; Whitehead KJ
    Genet Med; 2023 Aug; 25(8):100865. PubMed ID: 37125633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epistaxis severity score for hereditary hemorrhagic telangiectasia.
    Hoag JB; Terry P; Mitchell S; Reh D; Merlo CA
    Laryngoscope; 2010 Apr; 120(4):838-43. PubMed ID: 20087969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.